Sunil Healthcare Intrinsic Value
SUNLOC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹85.36 | ₹68.29 - ₹102.43 | +22.9% | EPS: ₹3.88, Sector P/E: 22x |
| Book Value Method | asset | ₹134.00 | ₹120.60 - ₹147.40 | +92.9% | Book Value/Share: ₹67.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹138.94 | ₹125.05 - ₹152.83 | +100.0% | Revenue/Share: ₹96.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹138.94 | ₹125.05 - ₹152.83 | +100.0% | EBITDA: ₹16.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹111.41 | ₹89.13 - ₹133.69 | +60.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹24.83 | ₹22.35 - ₹27.31 | -64.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹59.95 | ₹53.96 - ₹65.95 | -13.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹40.00 | ₹36.00 - ₹44.00 | -42.4% | ROE: 6.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹76.48 | ₹68.83 - ₹84.13 | +10.1% | EPS: ₹3.88, BVPS: ₹67.00 |
Want to compare with current market value? Check SUNLOC share price latest .
Valuation Comparison Chart
SUNLOC Intrinsic Value Analysis
What is the intrinsic value of SUNLOC?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sunil Healthcare (SUNLOC) is ₹85.36 (median value). With the current market price of ₹69.47, this represents a +22.9% variance from our estimated fair value.
The valuation range spans from ₹24.83 to ₹138.94, indicating ₹24.83 - ₹138.94.
Is SUNLOC undervalued or overvalued?
Based on our multi-method analysis, Sunil Healthcare (SUNLOC) appears to be trading below calculated value by approximately 22.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.03 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.42 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 6.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.59x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Sunil Healthcare
Additional stock information and data for SUNLOC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-15 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹8 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹23 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹17 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |